From: Bcl-2 expression is altered with ovarian tumor progression: an immunohistochemical evaluation
 | Normal | Cysts | Cystadenomas | WD (Grade 1) | MD (Grade 2) | PD (Grade 3) |
---|---|---|---|---|---|---|
 | (n = 2) | (n = 4) | (n = 13) | (n = 3) | (n = 6) | (n = 19) |
Age (years) | Â | Â | Â | Â | Â | Â |
   Mean (SD) | 57.5 (12.0) | 58.0 (16.1) | 65.0 (10.1) | 48.7 (6.5) | 64.8 (16.7) | 62.7 (14.5) |
   Range | 49-66 | 48-81 | 49-79 | 42-55 | 33-76 | 33-88 |
Histology | Â | Â | Â | Â | Â | Â |
   Serous | N/A | 1 | 11 | 1 | 6 | 19 |
   Mucinous | N/A | 0 | 1 | 0 | 0 | 0 |
   Endometrioid | N/A | 0 | 0 | 2 | 0 | 0 |
   Other | N/A | 3 | 1 | 0 | 0 | 0 |
Stage | Â | Â | Â | Â | Â | Â |
   I | N/A | N/A | N/A | 0 | 0 | 1 |
   II | N/A | N/A | N/A | 1 | 0 | 0 |
   III | N/A | N/A | N/A | 2 | 6 | 17 |
   IV | N/A | N/A | N/A | 0 | 0 | 1 |